Comment
Author: Admin | 2025-04-28
Key TakeawaysEli Lilly has launched a service called LillyDirect that allows patients to get its weight loss drug Zepbound and other medications directly. The service can facilitate care for obesity, diabetes, and migraine.On the website, you can also search for independent telehealth providers or in-person care for these conditions. The drugmaker Eli Lilly launched a new platform called LillyDirect, which connects patients with independent providers who can prescribe obesity medications, including Lilly's new drug Zepbound. The website's online pharmacy allows patients to order some of Lilly's medications for obesity, migraine, or diabetes as long as they have a prescription. “A complex U.S. healthcare system adds to the burdens patients face when managing a chronic disease. With LillyDirect, our goal is to relieve some of those burdens by simplifying the patient experience to help improve outcomes,” said David A. Ricks, Lilly’s chair and CEO, in a statement. Lilly has employed different telehealth companies to service each condition: Form for obesity, Cove for migraine, and 9amHealth for diabetes. LillyDirect can also connect patients with an in-person provider for each condition, as well as facilitate prescription home delivery—if the prescription is for a Lilly-manufactured drug. Medication options offered through the pharmacy arm of LillyDirect are limited to Zepbound, an injectable weight loss drug, Emgality, an injection to treat migraine, and several insulin products to treat diabetes. More drugs are expected to be added. Zepbound: New and In-Demand LillyDirect offers another way to access the popular and highly effective tirzepatide. The drug, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, earned FDA for the latter in November 2023. It’s even more effective than its rival, semaglutide, marketed as Ozempic for type 2 diabetes and Wegovy for weight management. The efficacy of these drugs has made them hugely popular, contributing to shortages—compounded by the fact that the diabetes drugs are often prescribed off-label for weight loss.While Lilly manufactures both Zepbound and Monjaro, Mounjaro is not currently an option on LillyDirect. Patients who are interested in Zepbound can navigate directly to the pharmacy section of LillyDirect. But the platform can be used
Add Comment